We describe Dendropsophus ozzyi sp. nov., a new species of treefrog, tentatively included in the Dendropsophus microcephalus Group and most notably diagnosed by the presence of pointed fingers and an advertisement call with a very high dominant frequency. The new species is known from three localities in the Brazilian Amazon forest, two on western State of Pará and one (the type locality) in eastern State of Amazonas (03°56'50"S and 58°26'36"W, 45 m a.s.l.).
For nearly 40 years Bolitoglossa paraensis has been synonymized with Bolitoglossa altamazonica. This fact has been mainly related to taxonomic ambiguities arising from the morphological similarities between these species and the scarcity of material deposited in collections. However, during the past 30 years new material of Bolitoglossa has been collected in many places throughout the Brazilian Amazonia, including the type locality of B. paraensis, Santa Isabel do Pará. In this article we designate the neotype of B. paraensis based on new material from the type locality, correct misinterpretations about this name. We determined how many species of the genus Bolitoglossa occur in Brazilian Amazonia, described three new species, B. caldwellae sp. nov., B. madeira sp. nov., and B. tapajonica sp. nov., provide a key for identifying Brazilian salamanders. Were analyzed two hundred and seventy eight specimens of Bolitoglossa from the Brazilian states of Acre, Amapá, Amazonas, Pará, and Rondônia; morphological data of B. altamazonica from Colombia were used for comparison purposes. We confirm the presence of B. altamazonica in extreme western Brazil, and expand the number of species occurring in Brazilian Amazonia to five.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.